A Systematic review on randomized clinical trials for direct oral anticoagulant in subjects with acute coronary syndrome: primary and secondary outcomes.

Background: In recent years, direct oral anticoagulant (DOAC) has been projected for secondary prevention of recurrent ischemic events post-acute coronary syndrome (ACS). However, there is still uncertainty about the efficacy/safety of DOACs in sub-populations. We hypothesized that for those with AC...

Descripción completa

Detalles Bibliográficos

Publicado en:	Pharmacy Practice (1886-3655) Vol. 22; no. 2; pp. 1 - 24
Autores principales:	AlMazrouei, Nadia, Elnour, Asim Ahmed, Al Khidir, Israa Y., Alharbi, Fai Mutaz, Alshammari, Hajer Shaty, Altwalah, Shroog Farhan, Alshammari, Aliyah Hamdan, Alshammari, Talal Ahmed, Alhajaji, Ibrahim Khalid, Alshammari, Majd Habib, Aljohani, Norah, Khaled, Yasmin, Alanazi, Shahd, Beshir, Semira Abdi, Menon, Vineetha
Formato:	forms glossary research systematic review tables/charts Journal Article
Publicado:	Centro de Investigaciones y Publicaciones Farmaceuticas S.L. Apr-Jun2024
Acceso en línea:	Ver este registro en EBSCOhost